Publications by authors named "Alessio David"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,560

Total Likes

118

Extended Reach

125,555

Social Features

50
C
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
Stephen J Nicholls, Imre Pavo, Deepak L Bhatt, John B Buse, Stefano Del Prato, David D'Alessio

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Action of Imapextide, a Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy Volunteers.
Elisa Fabbrini, Anastasiya Koshkina, Michael Hackett, Michael Zhao, Kishore Thalluri, David A D'Alessio

J Clin Endocrinol Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalizability of SURPASS-CVOT to the United States: A Nationally Representative Study.
Rahul Aggarwal, Stephen J Nicholls, David D'Alessio, Deepak L Bhatt

Prog Cardiovasc Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α cells use both PC1/3 and PC2 to process proglucagon peptides and control insulin secretion.
Canqi Cui, Danielle C Leander, Sarah M Gray, Kimberley El, Alex Chen, David A D'Alessio

Sci Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β Cell Gαs signaling is critical for physiological and pharmacological enhancement of insulin secretion.
Megan E Capozzi, David Bouslov, Ashot Sargsyan, Michelle Y Chan, Alex Chen, David J Hodson, David A D'Alessio

J Clin Invest· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REVISITING GLUCAGON ACTION IN DIABETES: IS IT ALL BAD?
David A D'Alessio

Trans Am Clin Climatol Assoc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NIDDK at 75 Years of Age: Great Triumphs but Concerns for Its Longevity.
Steven E Kahn, Cheryl A M Anderson, John B Buse, Elizabeth Selvin, David A D'Alessio

Diabetes· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NIDDK at 75 Years of Age: Great Triumphs but Concerns for Its Longevity.
Steven E Kahn, Cheryl A M Anderson, John B Buse, Elizabeth Selvin, David A D'Alessio

Diabetes Care· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose-dependent insulinotropic polypeptide (GIP).
Timo D Müller, Alice Adriaenssens, Bo Ahrén, Matthias Blüher, Andreas L Birkenfeld, David D'Alessio

Mol Metab· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Normal 93: Linking the β-Cell and Insulin Sensitivity: Revisiting a 1993 Diabetes Classic by Kahn et al.
David D'Alessio, Steven E Kahn

Diabetes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Insulin Radioimmunoassay, the Watershed Moment in Diabetes Research: Revisiting 1960 Diabetes Classics by Berson and Yalow.
David A D'Alessio

Diabetes· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of glucagon-like peptide-1 receptor agonists on diabetic retinopathy: A meta-analysis of clinical studies emphasising retinal changes as a primary outcome.
Ishani Kapoor, Swara M Sarvepalli, David A D'Alessio, Majda Hadziahmetovic

Clin Exp Ophthalmol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes Spotlight: A New Addition to the Journal.
David A D'Alessio

Diabetes· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.
David A D'Alessio, Steven E Kahn

Diabetes· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.
David A D'Alessio, Steven E Kahn

Diabetes Care· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature.
David A D'Alessio, Steven E Kahn, Hindrik Mulder

Diabetologia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal Feature.
David A D'Alessio, Steven E Kahn, Hindrik Mulder

Diabetes Care· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Gut Microbiota and Diabetes: Clarity on an Emerging Topic and Introduction to a New Partnership and Journal Feature.
David A D'Alessio, Steven E Kahn, Hindrik Mulder

Diabetes· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes.
Hüsün S Kizilkaya, Kimmie V Sørensen, Jakob S Madsen, Peter Lindquist, Jonathan D Douros, David A D'Alessio

Nat Metab· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes.
Jonah A Hoyt, Emily Cozzi, David A D'Alessio, Chris C Thompson, Vanita R Aroda

Diabetes Obes Metab· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Doses of Exogenous Glucagon Stimulate Insulin Secretion and Reduce Insulin Clearance in Healthy Humans.
Sarah M Gray, Elisha Goonatilleke, Michelle A Emrick, Jessica O Becker, Andrew N Hoofnagle, David A D'Alessio

Diabetes· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.
Stephen J Nicholls, Santiago Tofé, Carel W le Roux, David A D'Alessio, Russell J Wiese

Cardiovasc Diabetol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon as the First Incretin: Objects (in the Rearview Mirror) Are Closer Than They Appear.
David A D'Alessio, Vincent Marks

Diabetes· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the incretin effect in healthy subjects: concordance between clamp and OGTT methods.
Benedikt A Aulinger, David A D'Alessio

Am J Physiol Endocrinol Metab· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis